MedTrace Logo

The Health Effect of Diet Rich in Nordic Berries

NCT01414647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2018-05-17

No results posted yet for this study

Summary

Dietary polyphenols might have beneficial effects on glucose and lipid metabolism based on the studies made in animals or cell cultures. The findings regarding the possible decrease of low-grade inflammation are existing also in humans. Low-grade inflammation has been suggested to be a mechanistic link between obesity and its consequences on cardiometabolic health. The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers.

Conditions

  • Metabolic Syndrome
  • Impaired Glucose Tolerance
  • Low-grade Inflammation
  • Dyslipidemia

Interventions

DIETARY_SUPPLEMENT

300 g of strawberry, raspberry and cloudberry

100 g of strawberry puree, 100 g of frozen raspberries and 100 g frozen cloudberries were concumed daily for 8 weeks. Bilberry consumption was restricted.

DIETARY_SUPPLEMENT

400 g of bilberry

Equivalent amount to 400 g of fresh bilberries were consumed as 40 g of dried bilberries and as 200 g of frozen bilberries. Restriction of use of strawberries, raspberries and cloudberries were set.

OTHER

Control diet

Control diet, ie. habitual diet with restriction of berry consumption was consumed for eight weeks

Sponsors & Collaborators

  • VTT Technical Research Centre, Finland

    collaborator OTHER

  • Marjukka Kolehmainen

    lead OTHER

Principal Investigators

  • Riitta Törrönen, Adjunct Professor · University of Eastern Finland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2006-12-31
Completion
2010-03-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01414647 on ClinicalTrials.gov